Pfizer climbs 2% as FDA nears final authorization of its COVID-19 vaccine

Pfizer climbs 2% as FDA nears final authorization of its COVID-19 vaccine

Business Insider

Published

Regulators are now working "rapidly" to finalize authorization of Pfizer's shot, FDA Commissioner Stephen Hahn said in a Friday statement.

Full Article